News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Evogen and LGC License High Sensitivity Novel HyBeacons(R) PCR Probe Technology


1/13/2009 10:46:06 AM

KANSAS CITY, Mo. & WHITE MARSH, Md. & BATH, United Kingdom & TEDDINGTON, United Kingdom--(BUSINESS WIRE)--Evogen, Inc., a global molecular diagnostics company, and LGC, an international science-based company and recognised provider of laboratory services and measurement standards, announced today that they have signed a worldwide license agreement of LGC’s HyBeacons® PCR probe chemistry technology to Evogen to augment the recently launched rapid molecular diagnostics and detection platform, including the flagship instrument, the EvoCycler™ HD12. This license gives Evogen exclusive and sub-licensable rights to the HyBeacons technology within its key market areas.

Read at BioSpace.com

comments powered by Disqus
Evogen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES